Humana execs sell $38M in shares

Amy Baxter | | Health Exec | Policy & Regulations

Humana’s top executives offloaded a significant sum of shares in late December, shedding about 107,077 Humana shares worth $37.7 million, Louisville Business First reported.

The selloff comes at a time when Humana’s share prices have been soaring, closing at a new all-time high of $365.88 on Dec. 16. Higher company earnings are matched with a rosy outlook for corporate tax cuts. In fact, 15 of Humana’s highest share price closings fell in November and December.

Humana CEO Bruce Broussard sold 62,700 shares for roughly $21.7 million, according to public filings.

Humana’s share prices, along with other major healthcare insurers, jumped on the news that a handful of Affordable Care Act taxes could be eliminated.

See the full story below:

Humana CEO, other execs offload $38M in company shares

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Healthcare-specific AI: How to multiply successes and head off accidents
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary
FDA issues Class I recall on insertion tubes after manufacturing error
FDA recalls brain biopsy needles due to stainless steel debris
Michigan doctor claims he was fired for reporting unnecessary pacemaker surgeries
UnitedHealth successfully sues CMS over disputed phone call

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”